MedPath

Hybrid L24 New Enrollment Post Approval Study

Not Applicable
Completed
Conditions
High Frequency Sensorineural Hearing Loss
Interventions
Device: Nucleus Hybrid L24 Implant
Registration Number
NCT02379819
Lead Sponsor
Cochlear
Brief Summary

This study evaluates the long term safety and effectiveness of the Nucleus Hybrid L24 Implant in a group of newly implanted adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria

Ear to Be Implanted:

  • Normal to moderate hearing loss in the low frequencies with severe to profound mid to high frequency hearing loss in the ear to be implanted
  • CNC word recognition of 10-60% in the ear to be implanted

Contralateral Ear:

  • Moderately severe to profound mid to high frequency hearing loss in the contralateral ear
  • CNC word recognition equal to or better than that in the ear to be implanted but not more than 80% correct
Exclusion Criteria
  • not proficient in English
  • unwilling and/or unable to comply with the test protocol
  • deafness due to lesions of the acoustic nerve or central auditory pathway.
  • active middle-ear disease, with or without tympanic membrane perforation.
  • absence of cochlear development.
  • duration of severe to profound hearing loss of 30 years or greater

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Nucleus Hybrid L24 ImplantNucleus Hybrid L24 ImplantAdults age 18 and over who meet FDA criteria for unilateral implantation with the Nucleus Hybrid L24 Implant.
Primary Outcome Measures
NameTimeMethod
Change in Consonant-Nucleus-Consonant (CNC) Word Recognition in Quiet for the Two Listening Conditions: Implant Ear Alone and When Using Both Ears Together From Pre-operatively Through 3 Years Post-activation of the DeviceFrom pre-operatively through 3 years post-activation of the device

The CNC Words test consists of 10 recorded lists of 50 monosyllabic words in CD format. For this study, two lists will be administered in quiet at a level equal to 60 dBA in the sound field and recorded as a total number of words correct, which will be expressed as a percentage correct for this study. The CNC word test has a score range of 0-100% with higher values indicating better scores.

Number of Device or Procedure Related Adverse EventsUp to 5 years post-activation of the device
Secondary Outcome Measures
NameTimeMethod
Change in AzBio Sentence Recognition in Noise in the Best Unilateral ConditionPre-operatively, up to 3 years post-activation of the device

The AzBio Sentence Tests consists of 15 lists of 20 sentences each. AzBio sentences are spoken by different talkers in a conversational style with limited contextual cues that the listener can use to predict or 'fill in' unintelligible words. Each list includes 5 sentences from 4 different male and female speakers. Each word in the sentence counts toward the overall score and the resulting score is presented in percent correct. The AzBio sentence test has a score range of 0-100% with higher values indicating better scores.

Trial Locations

Locations (19)

Rocky Mountain Ear Center

๐Ÿ‡บ๐Ÿ‡ธ

Englewood, Colorado, United States

Greater Baltimore Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

Pittsburgh Ear Associates

๐Ÿ‡บ๐Ÿ‡ธ

Pittsburgh, Pennsylvania, United States

University of Colorado Hospitals

๐Ÿ‡บ๐Ÿ‡ธ

Aurora, Colorado, United States

Arizona Ear Center

๐Ÿ‡บ๐Ÿ‡ธ

Phoenix, Arizona, United States

Vanderbilt University Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

Michigan Ear Institute

๐Ÿ‡บ๐Ÿ‡ธ

Farmington Hills, Michigan, United States

Lahey Hospital and Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Burlington, Massachusetts, United States

University of Miami

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Denver Ear Associates

๐Ÿ‡บ๐Ÿ‡ธ

Englewood, Colorado, United States

Kaiser Permanente South Sacramento

๐Ÿ‡บ๐Ÿ‡ธ

Sacramento, California, United States

NorthShore University Health System

๐Ÿ‡บ๐Ÿ‡ธ

Northbrook, Illinois, United States

University of Iowa

๐Ÿ‡บ๐Ÿ‡ธ

Iowa City, Iowa, United States

University of Michigan

๐Ÿ‡บ๐Ÿ‡ธ

Ann Arbor, Michigan, United States

Midwest Ear Institute

๐Ÿ‡บ๐Ÿ‡ธ

Kansas City, Missouri, United States

Ohio Ear Institute

๐Ÿ‡บ๐Ÿ‡ธ

Westerville, Ohio, United States

The University of Cincinnati

๐Ÿ‡บ๐Ÿ‡ธ

Cincinnati, Ohio, United States

Hospital of the University of Pennsylvania

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Ear Institute of Texas

๐Ÿ‡บ๐Ÿ‡ธ

San Antonio, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath